IPCA Laboratories Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: IPCALAB BSE: 524494

₹1927.00

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #15 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
IPCA Laboratories Limited (this stock)	48,889	39.3	12.4%	45.2%	—	79	9	49

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹48,812 Cr

EV / EBITDA

24.3x

EV / Sales

6.33x

Market cap / Sales

6.34x

Earnings yield

2.54%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 2,137 Cr, up 20.6% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 373 Cr, up 42.5% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	2,119	515	373	₹14.7100
March 31, 2026	1,814	350	262	₹10.3400
Dec. 31, 2025	1,845	417	303	₹11.9600
Sept. 30, 2025	1,930	408	305	₹12.0100
June 30, 2025	1,747	357	262	₹10.3300
March 31, 2025	1,638	17	-65	₹
Dec. 31, 2024	1,663	356	268	₹10.5500
Sept. 30, 2024	1,811	339	244	₹9.6200
June 30, 2024	1,566	288	204	₹8.0500
March 31, 2024	1,511	127	65	₹2.5500
Dec. 31, 2023	1,507	200	137	₹5.4000
Sept. 30, 2023	1,663	245	162	₹6.3900
June 30, 2023	1,489	250	167	₹6.5700

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	2,137	1,844	1,863	1,952	1,772	1,680	1,828	1,581	1,526	1,524	1,699	1,532	1,435
Operating revenue	2,119	1,814	1,845	1,930	1,747	1,663	1,811	1,566	1,511	1,507	1,663	1,489	1,402
Other income	17	30	18	22	25	17	17	15	15	17	36	43	33
Operating expenses	1,542	1,383	1,368	1,466	1,340	1,252	1,409	1,213	1,218	1,233	1,354	1,191	1,226
Operating profit	578	431	477	465	407	411	402	353	292	273	309	298	176
Operating profit margin	27.3%	23.8%	25.9%	24.1%	23.3%	24.7%	22.2%	22.6%	19.4%	18.2%	18.6%	20.0%	12.5%
Depreciation	75	70	69	67	63	63	63	61	62	63	61	60	59
Interest	5	10	10	11	12	10	17	19	24	27	39	31	18
Exceptional items, gain / (loss)	—	-30	—	—	—	—	—	—	-94	—	—	—	—
Profit before tax	515	350	417	408	357	356	339	288	127	200	245	250	132
Tax	142	88	114	104	95	88	95	84	63	63	83	83	47
Net profit	373	262	303	305	262	268	244	204	65	137	162	167	85
EPS	14.71	10.34	11.96	12.01	10.33	10.55	9.62	8.05	2.55	5.40	6.39	6.57	3.34
Net profit (TTM)	1,244	1,133	1,138	1,078	978	781	650	568	530	550	534	539	517
EPS (TTM)	49.02	44.64	44.85	42.51	38.55	30.77	25.62	22.39	20.91	21.70	21.04	21.26	20.36

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	7,337	1,532	1,133
March 31, 2025	6,678	1,000	651
March 31, 2024	6,166	822	530
March 31, 2023	5,815	750	506

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	7.8%	7.4%	7,431^†	—	6,278^†	5,929^†	5,455^†	5,201^†	4,432^†	3,688^†	3,259^†	3,166^†
Operating revenue	8.1%	7.4%	7,337	6,678	6,166	5,815	5,399^†	5,139^†	4,367^†	3,633^†	3,219^†	3,144^†
Other income	—	—	95^†	—	111^†	114^†	56^†	62^†	65^†	55^†	40^†	22^†
Operating expenses	—	—	5,556^†	—	4,996^†	4,870^†	4,156^†	3,626^†	3,453^†	2,940^†	2,778^†	2,690^†
Operating profit	23.5%	3.3%	1,780^†	—	1,170^†	945^†	1,244^†	1,514^†	915^†	693^†	442^†	454^†
Operating profit margin	—	—	24.3%^†	—	19.0%^†	16.3%^†	23.0%^†	29.5%^†	20.9%^†	19.1%^†	13.7%^†	14.4%^†
Depreciation	—	—	269^†	—	246^†	225^†	204^†	188^†	179^†	172^†	174^†	171^†
Interest	—	—	44^†	—	121^†	44^†	7^†	8^†	16^†	18^†	24^†	23^†
Exceptional items, gain / (loss)	—	—	-30^†	—	-94^†	0^†	0^†	0^†	0^†	0^†	0^†	-4^†
Profit before tax	26.9%	2.1%	1,532	1,000	822	750	1,088^†	1,380^†	785^†	557^†	283^†	258^†
Tax	—	—	400^†	—	292^†	248^†	217^†	239^†	133^†	102^†	50^†	70^†
Net profit	30.8%	-0.1%	1,133	651	530	506	871^†	1,141^†	652^†	455^†	233^†	188^†
EPS	29.9%	-13.1%	44.64^†	—	20.91^†	20.36^†	55.71^†	90.12^†	51.63^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	24.3%^†	—	19.0%^†	16.3%^†	23.0%^†	29.5%^†	20.9%^†	19.1%^†	13.7%^†	14.4%^†
EBIT margin	21.5%^†	—	15.3%^†	13.7%^†	20.3%^†	27.0%^†	18.3%^†	15.9%^†	9.5%^†	9.0%^†
PBT margin	20.9%	15.0%	13.3%	12.9%	20.2%^†	26.9%^†	18.0%^†	15.3%^†	8.8%^†	8.2%^†
Net margin	15.4%	9.7%	8.6%	8.7%	16.1%^†	22.2%^†	14.9%^†	12.5%^†	7.2%^†	6.0%^†
Interest coverage	36.21x^†	—	7.81x^†	18.09x^†	151.95x^†	170.53x^†	50.71x^†	31.15x^†	12.77x^†	12.06x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	2.82x	2.67x	—	—	—	—	—	—	—	—
Quick ratio	1.61x	1.58x	—	—	—	—	—	—	—	—
Debt to equity	0.03x	0.13x	—	—	—	—	—	—	—	—
Return on equity	14.2%	9.4%	—	—	—	—	—	—	—	—
Return on assets	11.6%	7.2%	—	—	—	—	—	—	—	—
Return on capital employed	18.9%^†	—	—	—	—	—	—	—	—	—
Asset turnover	0.75x	0.74x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	1,378	-697	-745	665	713
March 31, 2025	1,374	-739	-428	603	771
March 31, 2024	831	-1,355	-465	360	470
March 31, 2023	762	-710	506	437	325
March 31, 2022	840	-824	426	446	394

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	9,776	7,979	7,954	165	70	3,995	1,419	312	2,935	1,708
March 31, 2025	9,071	6,892	6,866	389	482	3,780	1,418	77	2,503	1,542
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.